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University of Western Australia, Fremantle Hospital, Fremantle, WA 6959, AustraliaDespite a number of large randomised trials (with
more underway) the management of small abdominal
aortic aneurysms remains controversial.1–3 In this
issue of the European journal of vascular and
endovascular surgery Vega de Ceniga and colleagues
report on the growth rate of abdominal aortic
aneurysms measuring !5 cm in maximum diameter
followed for a mean of four and half years.4 The
authors divide the patients into two groups with aortic
diameters measuring 3–3.9 cm (nZ246) and 4–4.9 cm
(nZ106) imaged by annual ultrasound and 6-monthly
CT, respectively. The authors report that the larger
aneurysms grow at over twice the rate of smaller
aneurysms (4.7 compared to 2.1 mm/year) and using
Kaplan–Meier analysis estimated that 56 and 82%
compared to 2 and 18% of aortas reached 5 cm
diameter by 2 and 5 years, respectively.4
The study of aortic aneurysm growth has important
implications in a number of areas, including under-
standing the pathogenesis of the disease, as a basis for
comparison with aortic diameters following endovas-
cular aneurysm repair (EVAR) and in order to develop
new treatment protocols. At present the treatment of
small aneurysms is conservative in most centres with
intervention reserved for those expanding to beyond a
diameter limit of between 5 and 5.5 cm. Evidence in
support of this policy is provided by two large
randomised trials which showed no advantage of
early surgery for aortic aneurysms measuring a
maximum diameter of 4–5.5 cm, and demonstrated it
was safe to follow an ultrasound surveillance
approach with intervention primarily determined by
growth to the intervention diameter.1,2 Despite thising author. Prof. Jonathan Golledge, Director, The
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aneurysm using EVAR, which is associated with lower
early and medium term aneurysm-related mortality
than open surgery.5,6 Based on the findings of Vega de
Ceniga et al., it could be argued that since the majority
of 4–4.9 cm aneurysms are going to reach 5 cm within
2–5 years EVAR could reasonably by undertaken at
aortic diameters under 5 cm. Prior to accepting this
approach a number of issues need to be considered,
namely the calculation of aneurysm growth, the long-
term outcome and cost of EVAR and the opportunity
to develop medical treatments for aortic aneurysms.
The study of aneurysm progression using maximal
diameter is hampered by the variable growth pattern
of aneurysms, the loss of patients undergoing inter-
vention or coming to the end of follow-up and the
measurement error of the imaging modality.7,8 The
variation in aortic aneurysm growth patterns has
received little attention. In a recent report of the UK
Small Aneurysm Trial (UKSAT), Brady and colleagues
reported a variety of growth patterns in patients
followed-up for many years characterised by growth
spurts and periods of stasis and in 6.4% aneurysm
regression.7 Vega de Ceniga et al. noted no aneurysm
growth in 25 and 18% of 3–3.9 and 4–4.9 cm
aneurysms, respectively.4 In calculating mean aneur-
ysm expansion rates many authors use a statistical
model in order to represent the behaviour of the
cohort, such as linear regression, quadratic model or
exponential growth. The variation in aneurysm
growth is rarely taken into account with most authors
using linear regression, which has been found to be
less representative than a quadratic model.7 The
random nature of growth and losses to follow-up
due to intervention has been interpreted as requiring a
Bayesian multilevel random effects model using
quadratic regression terms.7 On the basis of thisEur J Vasc Endovasc Surg 31, 237–238 (2006)
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linear regression approach over-estimates aneurysm
growth rate by 29%.7 While Vega de Ceniga and
colleagues did not outline their method of growth
calculation it is assumed a linear expansion model was
employed and may be one reason why they reported a
greater percentage of aneurysms expanding to inter-
vention level at 5 years than noted in the small
aneurysm trials (around 60% at 5 years).1,2
The recent EVAR 1 trial reported that aneurysm
related mortality was slightly lower in patients under-
going EVAR compared to open aortic surgery,
however, all cause mortality was equivalent and cost
and complications greater with EVAR.6 The re-
intervention rate was around 20% during the first 5
years following stent-graft insertion.6 Rather than
interpreting the findings of studies such as those of
Vega de Ceniga et al. as support for lowering the
diameter threshold for EVAR, we feel that the results
favour greater investigation of medical treatments for
aortic aneurysm. For example, Vega de Ceniga et al.
confirmed the intriguining observation that diabetes
and occlusive lower limb artery disease are associated
with reduced aneurysm expansion.4,7 A number of
suggestions have been made for the negative associ-
ation of diabetes with aneurysm presence and growth,
such as changes in extracellular matrix and proteol-
ysis.9 These important negative associations along
with the increased recognition of variable growth
patterns provide an important basis for investigations
of the mechanisms underlying aneurysm develop-
ment and progression. The great interest in extending
EVAR to smaller aneurysms would be benefited by an
equally strong push to develop drug therapies.Eur J Vasc Endovasc Surg Vol 31, 3 2006Acknowledgements
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